B. Martin (Brussels, Belgium), E. Jassem (Gdansk, Poland)
Changes in the expression of Glutathione S Transferase-π (GST-π) and P-glycoprotein (P-gp) in bronchoscopic specimen of patients with lung cancer before and after chemotherapy
G. Vlachogeorgos, E. Manali, C. Mermigkis, E. Blana, S. Legaki, N. Karagiannidis, V. Polychronopoulos (Athens, Greece)
|  |
P-glycoprotein (p-gp) and lung resistance protein (lrp), as predictive factors of response to platinum-based chemotherapy for lung cancer
G. Kotantoula, M. Fotinou, K. Papadopoulou, E. Tziralidis, H. Lambrakis, A. Paspali, M. Stoca, N. Georgatou, A. Papacharalambous (Athens, Greece)
| |
Level of glutation-S transferase in the assessment of chemotherapy response in nonsmall cell lung cancer
M. Unsal, I. Akpolat, L. Erkan, B. Kandemir (Samsun, Turkey)
| |
The effect of theobromine and pentoxifylline on L-1 sarcoma growth and vascularity in syngeneic balb/c mice
B. Bialas-Chromiec, E. Skopinska-Rozewska, M. M. Filewska, E. Sommer, U. Demkow, E. A. Rogala, H. Skurzak (Warsaw, Poland)
| |
Epstein-barr virus - associated lung cancer study
N. V. Sevostjyanova (Tomsk, Russia)
| |
Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer?
D. A. Ougrioumov, E. A. Kogan (Moscow, Russia)
| |
Peculiarities of IGF family in the lung cancer
G. E. Sagindikova, E. A. Kogan, G. Jaques (Moscow, Russia; Marburg, Germany)
| |
Human bronchogenic carcinoma cell-asociated VEGF-expression in balb-c-nunu mice
P. R. Grahmann, C. Weindl, N. Freudenberg, J. Hasse, P. Dieter (Jena, Freiburg/Baden-Württemberg, Dresden, Germany)
| |
High-sensitive-detection of VEGF-mRNA in nonsmall-cell lung cancer (NSCLC) metastases of lymphnodes by thyramide amplified in-situ hybridization
U. Stachetzki, B. Voss, S. Boehm, K. Junker, M. Wilhelm, T. Bruening, K. M. Mueller (Bochum, Germany)
| |
Aberrant methylation of p16 tumour suppresor gene and DAP kinase in nonsmall cell lung carcinomas
S. K. Park, Y. S. Kim, M. K. Lee (Pusan, South Korea)
| |
Detection of k-ras codon 12 mutations in human lung tumour tissue by REMS-PCR
I. Robinson, M. Fleischhacker, O. Holz, L. Welker, T. Beinert, R. Joerres, H. Magnussen (Grosshansdorf, Berlin, Germany)
| |
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy
L. V. Stelmakh, T. P. Ses, S. V. Orlov, A. L. Akopov (Saint-Petersburg, Russia)
| |
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL) 1-beta in small cell lung cancer
L. V. Stelmakh, T. P. Ses, S. V. Orlov, A. L. Akopov (Saint-Petersburg, Russia)
| |
Plasma total antioxidant status and erythrocyte antioxidant enzyme activities in lung cancer in Turkey
S. Yavuzer, S. Yavuzer, H. Fiçicilar, S. Demirtas (Ankara, Turkey)
| |
Angiogenic activity of NSCLC cells is inhibited by sulindac and sulphone metabolite of sulindac
E. A. Rogala, E. Skopinska-Rozewska, E. Sommer, W. Kupis, P. Rudzinski, R. Langfort (Warsaw, Poland)
| |
Serum levels of thrombopoietin (TPO) in patients with thrombocytosis due to lung cancer and in essential throbocythaemia (ET)
B. Werynska, R. Ramlau, M. Podolak-Dawidziak, R. Jankowska, K. Kuliczkowski, M. Golecki, I. Prajs (Wroclaw, Poznan, Poland)
| |